Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease is a research paper published in Pharmaceuticals (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Vanderbilt CTSA
Grant: UL1TR002243
NIA NIH HHS
Grant: AG061138
NICHD NIH HHS
Grant: P50 HD103537
NIA NIH HHS
Grant: R01 AG061138
NIH HHS
Grant: S10 OD016245
FWCI
2.41
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease